They waited too long to bring this matter into the light.
They have known since 1979 exactly what they could expect from the Pharmaceutical Industry. With known Big Pharma players residing in appointed
positions on regulatory boards all over the globe, there is no surprise here.
Instead of funding research into exclusively non-damaging solutions, they accept the 'margin of acceptable risk' approach, the hallmark of the
entrenched financial engineers behind most of our non-infectious woes.
Instead of looking out for the people, they are looking out for business, suspending rules,and inventing new contrived emergency situation to justify
their carelessness disguised as necessity.